Background Coronavirus disease 2019 (COVID-19)-associated acute kidney injury (AKI)
frequency, severity and characterization in critically ill patients has not been reported. Methods …

Background and Objectives To report the clinical, biological, and imaging features and
clinical course of a French cohort of patients with glial fibrillary acidic protein (GFAP) …

Background Chimeric antigen receptor (CAR) T-cell therapy can induce side-effects such as
cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (…

The optimal treatment strategy of COVID-19 in the intensive care unit (ICU) is still unclear. In
severe and critical COVID-19 patients, cytokine storm is associated with acute respiratory …

Objectives Current guidelines recommend cefazolin as an alternative to antistaphylococcal
penicillins (ASPs) in methicillin-susceptible Staphylococcus aureus (MSSA) infective …

Introduction The morbi-mortality related to infective endocarditis (IE) remains high as the
epidemiology has changed over the last years: ageing of patients, comorbidity and healthcare-…

Objectives In the last decades, the number of cancer patients admitted in intensive care units
(ICUs) for septic shock has dramatically increased. However, prognosis data remain scarce…

Background Immune checkpoint inhibitors (ICI) have transformed cancer treatment over the
last decade. Alongside this therapeutic improvement, a new variety of side effects has …

Background The role of respiratory coinfections at diagnosis of Pneumocystis jirovecii
pneumonia (PcP) on clinical impact has been underestimated. Methods A retrospective …

In nonoperated prosthetic valve endocarditis (PVE), long-term outcome is largely unknown.
We report the follow-up of 129 nonoperated patients with PVE alive at discharge. At 1 year, …